Login to Your Account

Alteogen set to start phase I testing for Herceptin biosimilar

By Haky Moon
Staff Writer

Tuesday, March 1, 2016

HONG KONG – A green light to launch clinical trials in Canada for one of its leading biosimilar products will give South Korean company Alteogen Inc. and its Brazilian partner a boost on the global market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription